Bristol-Myers Squibb and Flatiron Health, a curator of regulatory-grade real-world data for cancer research and real-world evidence (RWE) generation, expanded their relationship today by announcing a three-year collaboration agreement. Bristol-Myers Squibb will use Flatiron’s real-world data to accelerate its research and development efforts, as well as improve its ability to generate additional evidence on the use…
Giovanni Caforio Named Chairman of Bristol-Myers Squibb
Giovanni Caforio named chairman of Bristol-Myers Squibb’s board of directors. Bristol-Myers Squibb Company announced that the company’s board of directors has appointed Giovanni Caforio, M.D. as chairman of the board, effective May 2, the date of the company’s annual meeting of shareholders. Caforio, who will continue to serve as chief executive officer, will succeed current chairman Lamberto Andreotti,…